Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs

29 Jun 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to HER2/EGFR in Cancer Research
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26119941
DOI: 10.1038/onc.2015.249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designsPMID 26119941Read ↗

Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.Semantic proximity Read ↗

Targeted therapies for breast cancer.Semantic proximity Read ↗

TCGA's breast cancer project may yield important therapeutic benefits, but it's too early to be sure.Semantic proximity Read ↗

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategiesSemantic proximity Read ↗

Translating the TCGA breast cancer results into clinical practice: searching for therapeutic clues.Semantic proximity Read ↗

Therapeutic Advances and New Directions for Triple-Negative Breast CancerSemantic proximity Read ↗

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read ↗

Response-based molecular subtyping—emergence of the third generation of breast cancer subtypesSemantic proximity Read ↗

Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer.Semantic proximity Read ↗

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.